Cyprus approves the use of human COVID-19 medication molnupiravir to combat a local feline virus mutation causing feline infectious peritonitis resulting in numerous cat deaths locally. The government assures that there is no risk of depleting medication stocks for potential COVID-19 surges in the human population.